DEBRISOQUINE 4-HYDROXYLASE (CYP2D) LOCUS AND POSSIBLE SUSCEPTIBILITY TO SCHIZOPHRENIA

被引：20
|
作者：
VALLADA, H
COLLIER, D
DAWSON, E
OWEN, M
NANKO, S
MURRAY, R
GILL, M
机构：
[1] TEIKYO UNIV,SCH MED,DEPT PSYCHIAT,TOKYO 173,JAPAN
[2] UNIV WALES COLL MED,DEPT PSYCHOL MED,CARDIFF CF4 4XN,S GLAM,WALES
来源：
LANCET | 1992年 / 340卷 / 8812期
关键词：
D O I：
10.1016/0140-6736(92)93266-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：181 / 182
页数：2
相关论文
共 50 条
  • [41] The endogenous substrates of brain CYP2D
    Wang, Xiaoshuang
    Li, Jie
    Dong, Guicheng
    Yue, Jiang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 724 : 211 - 218
  • [42] IDENTIFICATION OF MUTATIONS IN THE CYP2D6 GENE THAT ALTER EXPRESSION OF DEBRISOQUINE-HYDROXYLASE
    MOIR, D
    SAXENA, R
    JONES, BF
    WEIFFENBACH, B
    CAPORASO, N
    RELLING, M
    EVANS, W
    SHAW, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 1740 - 1740
  • [43] Spectrophotometric assay for acetanilide 4-hydroxylase, an estimate of CYP1A2 enzyme activity
    Shertzer, HG
    Nebert, DW
    Senft, AP
    Dingeldein, M
    Genter, MB
    Dalton, TP
    TOXICOLOGY METHODS, 2001, 11 (02): : 81 - 88
  • [44] STRUCTURE AND EVOLUTION OF THE RAT AND HUMAN DEBRISOQUINE 4-HYDROXYLASE (P450IID) GENE SUBFAMILY
    GONZALEZ, FJ
    KIMURA, S
    MATSUNAGA, E
    UMENO, M
    AOYAMA, T
    SKODA, R
    VILBOIS, F
    HARDWICK, JP
    NEBERT, DW
    GELBOIN, HV
    MEYER, UA
    CYTOCHROME P-450 : BIOCHEMISTRY AND BIOPHYSICS /, 1989, : 564 - 567
  • [45] CYP2D activity in the brain acts independently from CYP2D in the liver to alter CNS drug levels and response
    Tyndale, R.
    Miksys, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S119 - S119
  • [46] QUINIDINE BUT NOT QUININE INHIBITS IN MAN THE OXIDATIVE METABOLIC ROUTES OF METHOXYPHENAMINE WHICH INVOLVE DEBRISOQUINE 4-HYDROXYLASE
    MURALIDHARAN, G
    HAWES, EM
    MCKAY, G
    KORCHINSKI, ED
    MIDHA, KK
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (05) : 471 - 474
  • [47] DEBRISOQUINE 4-HYDROXYLATION (CYP2D6) POLYMORPHISM IN JORDANIANS
    HADIDI, HF
    CHOLERTON, S
    MONKMAN, SC
    ARMSTRONG, M
    IRSHAID, YM
    RAWASHDEH, NM
    DALY, AK
    IDLE, JR
    PHARMACOGENETICS, 1994, 4 (03): : 159 - 161
  • [48] Molecular heterogeneity at the CYP2D gene locus in Nicaraguans: Impact of gene-flow from Europe
    Agundez, JAG
    Ramirez, R
    Hernandez, M
    Llerena, A
    Benitez, J
    PHARMACOGENETICS, 1997, 7 (04): : 337 - 340
  • [49] 3D QSAR of prolyl 4-hydroxylase inhibitors
    Baringhaus, KH
    Guenzler-Pukall, V
    Schubert, G
    Weidmann, K
    MOLECULAR MODELING AND PREDICTION OF BIOACTIVITY, 2000, : 345 - 346
  • [50] CYP2D mRNA analysis in conventional and mini pigs
    Skaanild, MT
    Friis, C
    DRUG METABOLISM REVIEWS, 2002, 34 : 61 - 61
12345